Healthcare provider profile · identity verified

Simon Lim Go, MD

Internal Medicine · NORFOLK, VA · NPI 1235790734

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	687	216
Amlodipine Besylate	Amlodipine Besylate	483	153
Losartan Potassium	Losartan Potassium	442	135
Rosuvastatin Calcium	Rosuvastatin Calcium	320	104
Levothyroxine Sodium	Levothyroxine Sodium	307	93
Hydrochlorothiazide	Hydrochlorothiazide	284	85
Simvastatin	Simvastatin	279	83
Omeprazole	Omeprazole	246	81
Pravastatin Sodium	Pravastatin Sodium	244	79
Furosemide	Furosemide	209	71
Tamsulosin Hcl	Tamsulosin Hcl	197	68
Metformin Hcl	Metformin Hcl	182	58
Metoprolol Succinate	Metoprolol Succinate	165	51
Metoprolol Tartrate	Metoprolol Tartrate	165	60
Gabapentin	Gabapentin	162	49
Montelukast Sodium	Montelukast Sodium	151	51
Alprazolam	Alprazolam	146	37
Lisinopril	Lisinopril	141	50
Metformin Hcl Er	Metformin Hcl	139	45
Carvedilol	Carvedilol	137	46
Eliquis	Apixaban	127	27
Pantoprazole Sodium	Pantoprazole Sodium	110	41
Sertraline Hcl	Sertraline Hcl	106	37
Allopurinol	Allopurinol	105	33
Trazodone Hcl	Trazodone Hcl	103	38
Spironolactone	Spironolactone	98	37
Atenolol	Atenolol	97	28
Glipizide Er	Glipizide	97	27
Zolpidem Tartrate	Zolpidem Tartrate	97	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	30
Albuterol Sulfate Hfa	Albuterol Sulfate	90	44
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	84	24
Escitalopram Oxalate	Escitalopram Oxalate	83	25
Tizanidine Hcl	Tizanidine Hcl	82	28
Hydralazine Hcl	Hydralazine Hcl	78	26
Alendronate Sodium	Alendronate Sodium	77	28
Jardiance	Empagliflozin	75	21
Fluticasone Propionate	Fluticasone Propionate	71	38
Famotidine	Famotidine	70	22
Potassium Chloride	Potassium Chloride	70	23
Tramadol Hcl	Tramadol Hcl	69	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	12
Ozempic	Semaglutide	62	15
Clopidogrel	Clopidogrel Bisulfate	61	24
Synthroid	Levothyroxine Sodium	61	17
Januvia	Sitagliptin Phosphate	60	15
Ezetimibe	Ezetimibe	58	21
Nifedipine Er	Nifedipine	58	21
Triamcinolone Acetonide	Triamcinolone Acetonide	58	22
Venlafaxine Hcl Er	Venlafaxine Hcl	55	16
Diclofenac Sodium	Diclofenac Sodium	54	16
Warfarin Sodium	Warfarin Sodium	51	16
Donepezil Hcl	Donepezil Hcl	48	12
Glimepiride	Glimepiride	45	13
Duloxetine Hcl	Duloxetine Hcl	44	15
Trulicity	Dulaglutide	44	11
Vitamin D2	Ergocalciferol (Vitamin D2)	43	15
Lorazepam	Lorazepam	41	11
Pioglitazone Hcl	Pioglitazone Hcl	41	14
Prednisone	Prednisone	41	21
Pregabalin	Pregabalin	41	16
Felodipine Er	Felodipine	40	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	13
Farxiga	Dapagliflozin Propanediol	37	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Azithromycin	Azithromycin	36	32
Finasteride	Finasteride	36	12
Glipizide	Glipizide	36	13
Methylprednisolone	Methylprednisolone	35	32
Meclizine Hcl	Meclizine Hcl	34	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	11
Ketoconazole	Ketoconazole	32	13
Lovastatin	Lovastatin	32	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	11
Spiriva Respimat	Tiotropium Bromide	31	suppressed
Hydrocortisone	Hydrocortisone	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	suppressed
Cephalexin	Cephalexin	29	18
Xarelto	Rivaroxaban	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Naproxen	Naproxen	26	17
Ramipril	Ramipril	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Doxepin Hcl	Doxepin Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	21
Verapamil Er	Verapamil Hcl	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	22	suppressed
Meloxicam	Meloxicam	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Indapamide	Indapamide	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	12
Celecoxib	Celecoxib	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	17	suppressed
Diazepam	Diazepam	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Temazepam	Temazepam	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Valsartan	Valsartan	14	suppressed
Colchicine	Colchicine	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Nadolol	Nadolol	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Gemtesa	Vibegron	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Primidone	Primidone	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error